Associação Brasileira de Hematología. Hemoterapia Terapia Celular

What Associação Brasileira de Hematología. Hemoterapia Terapia Celular does

ABHH (Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular) is a São Paulo-headquartered, Brazilian nonprofit professional medical association (Associação) that serves hematologists, hemotherapy physicians, onco-hematologists, medical residents, and students specializing in hematology, hemotherapy, and cell therapy. Its primary customer segments are practicing specialists, medical trainees, blood banks and transfusion services, and clinical research centers, with a secondary audience of hematology patients and patient associations served through awareness and access programs. The organization functions as the recognized national voice of the specialty, engaging directly with Brazilian health regulators ANVISA, CONITEC, and ANS on drug approvals, SUS technology incorporation, and supply shortages.

ABHH's product portfolio spans education, science, quality, and advocacy. Core educational assets include the Hemoteca exclusive content library (video lessons, webinars, courses), the HEMO.Educa distance-learning platform, the HEMO PLAY podcast, and free webinars. Scientific infrastructure includes the quarterly HTCT scientific journal, indexed in Web of Science, Scopus, PubMed/PMC, SciELO Brazil, LILACS, and ESCI; the open-access Plataforma de Estudos Clínicos for registering and searching ongoing studies; clinical consensus and guidelines; and Brazilian disease registries covering CLL, AML, Mantle Cell Lymphoma, and MDS. Quality programs include the CQI external quality control program for transfusion agencies and laboratories and the AABB & ABHH joint accreditation program. The annual HEMO congress is the flagship community-gathering event, complemented by career-development programs (Sangue Jovem academic leagues, residency support), social programs (Programa Um Só Sangue blood-donation initiative, Equidade program, patient information portal), and strategic data infrastructure via the HEMOBR partnership.

ABHH operates a hybrid community-led, event-driven go-to-market, monetizing through five revenue streams: annual membership dues (subscription/recurring), HTCT journal subscriptions, paid educational programs and courses, event registrations and sponsorships from the HEMO congress, and Science Pillar sponsorships from AstraZeneca, GSK, Eli Lilly, and Novartis. Distribution is domestic, delivered through the ABHH website (abhhoficial.com.br), the associado member portal, the congressohemo.com.br event site, and the hemoeduca.com.br e-learning platform. International collaboration occurs through mutual partnerships with AABB, ASH, EHA, ISTH, ISBT, IMS, GBRAM, and SOHO. No pricing, revenue, headcount, or membership figures are publicly disclosed.

Name

Associação Brasileira de Hematología. Hemoterapia Terapia Celular

Legal name

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular

Website

https://abhh.org.br

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ABHH is a Brazilian nonprofit professional medical association serving hematology, hemotherapy, and cell therapy professionals through educational platforms, the indexed HTCT journal, disease registries, accreditation programs, the annual HEMO congress, and regulatory advocacy with ANVISA, CONITEC, and ANS.

Ownership category

akta.pro rank

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Membership Dues: Annual membership fees from hematology, hemotherapy, and cell therapy professionals. Members receive access to exclusive content, journals, and benefits.
2. Scientific Journal HTCT: Quarterly indexed scientific publication (Web of Science, Scopus, PubMed/PMC, SciELO Brazil, LILACS, ESCI). Revenue generated through subscriptions and potentially author fees.
3. Educational Programs: Revenue from courses, webinars, and certification programs for healthcare professionals. Exclusive courses like Hemoterapia e Medicina Transfusional offered to members.
4. Events and Conferences: Annual HEMO congress and other educational events generate revenue through registrations and sponsorship.
5. Sponsorships: Pharmaceutical company sponsors (AstraZeneca, GSK, Lilly, Novartis) support science pillar activities, clinical studies platform, and educational content.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

ABHH is a Brazilian professional medical association that delivers an integrated portfolio of continuing education, scientific publishing, clinical research coordination, and quality assurance services to hematology, hemotherapy, and cell therapy professionals and institutions. Its core offerings include the Hemoteca and HEMO.Educa e-learning platforms, the HTCT scientific journal, the Plataforma de Estudos Clínicos for clinical trial coordination, the CQI external quality control program, and the joint AABB & ABHH accreditation program. Membership, sponsored events, and the annual HEMO Congress anchor the association's service model.

Product overview

ABHH (Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular) is a professional medical association offering a platform of interconnected educational, scientific, and quality assurance products and services. The core offerings include the Hemoteca and HEMO.Educa e-learning platforms for continuing education; the Plataforma de Estudos Clínicos for clinical trial coordination; the HTCT scientific journal for research dissemination; and Consensos/Diretrizes for clinical guidelines. Supporting programs include the CQI external quality control program, AABB & ABHH accreditation services, disease registries (CLL, AML, Mantle Lymphoma, MDS), and public health initiatives like Programa Um Só Sangue and Programa de Equidade. The annual HEMO Congress serves as the premier industry event. The portfolio also includes career development programs (residency support, Sangue Jovem student league), webinars, and the HEMO PLAY podcast channel.

Differentiator

Problem solved

Functional benefit

Products and services

• Hemoteca

Quantifiable outcome

• HTCT journal indexed in 6 major international databases including Web of Science, Scopus, and PubMed/PMC
• +2 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

25 partnerships are on record, tiered core and minor.

• AABB (American Association of Blood Banks)coreStrategic or Co-development PartnerGlobal partnership for blood banking and transfusion medicine standards. Joint accreditation program (AABB & ABHH) for institutions with Hemotherapy, Transfusion Services, and Cell Therapy services in both public and private systems.
• ASH (American Society of Hematology)coreStrategic or Co-development PartnerGlobal partnership with the premier US hematology professional organization for advancing the specialty through education, research, and professional development.
• EHA (European Hematology Association)coreStrategic or Co-development PartnerPartnership with the leading European hematology organization for knowledge exchange, educational content, and professional collaboration.
• ISTH (International Society on Thrombosis and Haemostasis)coreStrategic or Co-development PartnerCollaboration with international thrombosis and hemostasis society for guidelines, education, and research advancement.
• ISBT (International Society of Blood Transfusion)coreStrategic or Co-development PartnerPartnership for international standards and best practices in blood transfusion and transfusion medicine.
• ASFA (American Society for Apheresis)minorStrategic or Co-development PartnerCollaboration on apheresis-related education and clinical practice guidelines.
• IMS (International Myeloma Society)coreStrategic or Co-development PartnerJoint Educational Program on Multiple Myeloma conducted with ABHH and IMS, creating specialized educational content for myeloma specialists.
• SOHO (Society of Hematologic Oncology)minorStrategic or Co-development PartnerPartnership with hematologic oncology society for knowledge sharing and educational collaboration.
• HEMOBRcoreStrategic or Co-development PartnerStrategic partnership generating qualified knowledge intelligence on the specialty including medical residency data, blood usage statistics, and health technology consultations.
• AIBe (Associação Internacional de Biologia)minorStrategic or Co-development PartnerInternational biology association partnership for scientific collaboration.
• Multiple Myeloma HubminorGTM or Marketing PartnerMarketing and educational partnership for myeloma content hub providing resources for healthcare professionals.
• Lymphoma HubminorGTM or Marketing PartnerMarketing and educational partnership for lymphoma content hub.
• AML HubminorGTM or Marketing PartnerMarketing and educational partnership for acute myeloid leukemia content hub.
• GVHD HubminorGTM or Marketing PartnerMarketing and educational partnership for graft-versus-host disease content hub.
• ALL Hub (Acute Lymphoblastic Leukemia)minorGTM or Marketing PartnerMarketing and educational partnership for acute lymphoblastic leukemia content hub.
• MPN HubminorGTM or Marketing PartnerMarketing and educational partnership for myeloproliferative neoplasms content hub.
• GBRAMcoreStrategic or Co-development PartnerPartnership in the Joint Educational Program on Multiple Myeloma together with IMS, creating comprehensive myeloma education.
• AstraZeneca BrazilminorGTM or Marketing PartnerScience pillar sponsor supporting educational and research content.显
• GSK BrazilminorGTM or Marketing PartnerScience pillar sponsor supporting educational and research content.
• Eli Lilly BrazilminorGTM or Marketing PartnerScience pillar sponsor supporting educational and research content.
• Novartis BrazilminorGTM or Marketing PartnerScience pillar sponsor supporting educational and research content.
• Programa Um Só SanguecoreStrategic or Co-development PartnerABHH-led initiative to establish an annual calendar making blood donation a constant act in Brazil, engaging all stakeholders in the donation ecosystem.
• ANVISAcoreStrategic or Co-development PartnerBrazilian health regulatory agency collaboration on drug approvals, emergency registrations, and shortage management for hematology medications.
• CONITECcoreStrategic or Co-development PartnerBrazilian health technology assessment committee. ABHH advocates for incorporation of new technologies for hematology patients in SUS.
• ANS (Agência Nacional de Saúde Suplementar)coreStrategic or Co-development PartnerBrazilian supplemental health agency. ABHH engages on private health system matters affecting hematology patients.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• International Society on Thrombosis and Haemostasis (ISTH): Global scientific society covering thrombosis, hemostasis and related fields — a named ABHH partner. Comparable in providing congresses, guidelines, education and a membership community for specialists overlapping with ABHH's hemotherapy scope.
• AABB (Association for the Advancement of Blood & Biotherapies): US-based global association for blood banking, transfusion medicine and cellular therapies, and ABHH's joint accreditation partner. Directly comparable in setting standards for transfusion services and accrediting blood banks/hemotherapy institutions.
• European Hematology Association (EHA): Leading European hematology society and named ABHH partner. Closely mirrors ABHH's model of education, congress (EHA Congress), research support and clinical guidelines for hematology professionals.
• American Society of Hematology (ASH): The premier US hematology professional society and named strategic partner of ABHH. Directly comparable as a membership-based association delivering hematology education, journals, guidelines, advocacy and an annual congress (ASH Annual Meeting).
• International Society of Blood Transfusion (ISBT): International society focused on blood transfusion science and practice, and a named ABHH partner. Comparable as an international membership body driving transfusion-medicine education, standards and congress activity.

Regional players

• Sociedade Brasileira de Oncologia Clínica (SBOC): Brazilian clinical oncology society with overlapping membership (hematology/oncology specialists), congress, guidelines and advocacy activities. Closely adjacent peer serving a related Brazilian specialist audience.
• British Society for Haematology (BSH): UK national hematology society providing education, clinical guidelines, a journal (British Journal of Haematology) and an annual meeting. Strong structural analog to ABHH, serving a UK rather than Brazilian membership base.
• Sociedad Española de Hematología y Hemoterapia (SEHH): Spanish national hematology and hemotherapy society with similar membership, congress, journal and guideline activities. Highly comparable in scope and operating model to ABHH, but operates in a different (Spanish/European) market.
• Associação Médica Brasileira (AMB): Brazil's broad national medical association. Comparable as a membership-based medical society operating in Brazil, but ABHH is a specialty sub-society within AMB's wider ecosystem.

Emerging players

• International Myeloma Society (IMS): Global society focused on multiple myeloma and a core ABHH educational partner via the Joint Educational Program. Comparable as a disease-specific membership organization co-developing content with ABHH.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/abhhoficial
• YouTubeyoutube.com/channel/UCVT8bYSoNhggGRcyZa6NPTw
• Facebookfacebook.com/ABHHOficial
• LinkedInlinkedin.com/company/abhh?trk=biz-companies-cym
• Instagraminstagram.com/abhhoficial

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Associação Brasileira de Hematología. Hemoterapia Terapia Celular